M. Van Der Werf (Stockholm, Sweden), M. Ruhwald (Copenhagen, Denmark), D. Goletti (Rome, Italy), C. Herzmann (Borstel, Germany)
The pathogen-host interactions in pulmonary tuberculosis (PT)
O. Titarenko, M. Dyakova, V. Zhuravlev, O. Manicheva, D. Esmedlyaeva, N. Alexeyeva (Saint-Petersburg, Russian Federation)
|  |
Mutations in the genes of drug-resistant mycobacterium tuberculosis in Uzbekistan
N. Parpieva, V. Beloserkoves, K. Safaev, A. Shakirov (Tashkent, Uzbekistan)
| |
Improved detection of mycobacterium tuberculosis using an inhibitor-tolerant loop-mediated isothermal amplification
E. Aryan, Z. Meshkat, S. Z. Mirbagheri, A. H. Alvandi, H. Safdari, B. Riahi, M. Momen-Heravi (Mashhad, Kermanshah, Islamic Republic Of Iran)
| |
Usefulness of serum glycopeptidolipid core immunoglobulin A antibody in mycobacterium avium complex infection
N. Hamaguchi, M. Senba, K. Kajiwara, K. Ito, N. Miura, H. Makino, T. Kanematsu, H. Yokoyama, N. Hamaguchi (Matsuyama, Japan)
|  |
Prospects for new compounds tiosemikarbazonami class to create drugs with antituberculosis activity
G. Mozhokina, N. Elistratova, I. Solovieva (Moscow, Russian Federation)
| |
TNFalpha receptors on monocytes in peripheral blood mononuclear cells culture in active pulmonary tuberculosis
A. Alshevskaya, F. Kireev, J. Lopatnikova, Z. Laushkina, S. Sennikov (Novosibirsk, Russian Federation)
| |
Changes in plasma pyridoxal levels during standard treatment tuberculosis
M. Matsumoto, T. Sakurai, K. Tada, A. Ikeda, S. Ideguchi (Ono, Kobe, Japan)
| |
Retrospective investigation of patients positive for glycopeptidolipid-core antibody to mycobacterium avium complex pulmonary disease
Y. Oki, T. Ohnishi, S. Kusumoto, Y. Murata, S. Ohta, M. Yamamoto, Y. Watanabe, S. Suzuki, H. Ishida, T. Shirai, A. Tanaka, T. Yokoe, H. Sagara (Shinagawa, Japan)
| |
Immunologic biomarkers and lung injury in active pulmonary tuberculosis
R. Baez-Saldana, V. Gonzalez-Lopez, R. Lascurain-Ledezma, P. Gorocica-Rosete, R. Castro-Perez, A. Santillan-Martinez, Y. Chavarria-Castro (Mexico, Mexico)
| |
Association of serum cytokines with pulmonary tuberculosis treatment outcomes
H. Gupta, S. Kant, S. Singh, A. Jain, K. Srivastava (Lucknow, India)
| |
Antimicrobial peptide cathelicidin (LL- 37) and human beta-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis
E. Cakir, E. Torun, A. H. Gedik, T. Umutoglu, E. C. Aktas, U. Topuz, G. Deniz (Istanbul, Turkey)
| |
Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
L. Slogotskaya, E. Bogorodskaya, O. Sentchichina, D. Ivanova, V. Litvinov, P. Seltsovsky, D. Kudlay, N. Nikolenko, N. Kulikovskaya, T. Vaneeva (Moscow, Russian Federation)
| |
Activity of lysozyme and adenosine deaminase in patients with pulmonary tuberculosis
M. Trajcevska, A. Sandevski, L. Simonovska (Skopje, Fyrom)
| |
Usefulness of serum anti-glycopeptidolipid core IgA antibody assay for the diagnosis of pulmonary infection of mycobacterium avium complex
S. Arakawa, A. Yokoyama, Y. Shinno, K. Itahashi, A. Kamiyama, M. Kawakami, M. Suzuki, Y. Sakamoto (Tokyo, Japan)
| |
Diaskintest®- screening method in mass examination of the child population for tuberculosis in Russia
V. Aksenova, N. Klevno, T. Sevostyanova (Moscow, Russian Federation)
| |
A review of pleural fluid TB culture at a large acute UK hospital
S. Babu, S. Gunatilake, N. Whitehead, M. Reichmann, A. Chauhan (Portsmouth, United Kingdom)
| |
Xpert MTB/RIF testing of pooled induced sputum
M. Y. Chew, J. Ng, V. Palanichamy, T. K. Lim (Singapore, Singapore)
| |
Efficacy of endoscopic diagnostics in smear-negative TB
I. Sivokozov, I. Shumskaya, O. Lovacheva, G. Evgushenko, L. Chernousova (Moscow, Russian Federation)
| |
Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection
Y. Kobashi, M. Ikeda, K. Mouri, S. Kato, M. Oka (Kurashiki, Japan)
| |